Bohui Bio
Daxing
About Bohui Bio
Bohui Bio is a biotech company that engages in the clinical stage of drug research and development. Senior medication research and development professionals from pharmaceutical firms who returned to the neighborhood and focused on tumors and autoimmune illnesses helped co-found the organization. The company is dedicated to the development of global medications and has established a variety of research and development pipelines for unmet clinical requirements through the research and development strategy. The company has developed an immune function detection platform and a molecular coupling technology platform with the assistance of numerous reputable investment institutions in the sector.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $15.7M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2025)
- Website: broadenbio.com
- Phone: 010-58222729
Industries & Categories
Biotechnology
Canonical: https://fsome.com/organization/bohui-bio-5195 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.